Cargando…
Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
Introduction Management of periprosthetic hip infections (PHIs) generally consists of implant removal and thorough debridement, accompanied by appropriate antibiotic therapy. Daptomycin (DAP) is a novel antibiotic, which allowed for implant retention in several patients after treating their infected...
Autores principales: | Oe, Kenichi, Sawada, Masahiro, Nakamura, Tomohisa, Iida, Hirokazu, Saito, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298194/ https://www.ncbi.nlm.nih.gov/pubmed/34322334 http://dx.doi.org/10.7759/cureus.15842 |
Ejemplares similares
-
Linezolid versus daptomycin treatment for periprosthetic joint infections: a retrospective cohort study
por: Sawada, Masahiro, et al.
Publicado: (2019) -
Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
por: Shaw, E, et al.
Publicado: (2015) -
Daptomycin-Associated Diarrhea: A Case Report and Review of the Literature
por: Awadelkarim, Abdalaziz M, et al.
Publicado: (2022) -
Addition of daptomycin for the treatment of pneumococcal meningitis: protocol for the AddaMAP study
por: Chavanet, Pascal, et al.
Publicado: (2023) -
The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
por: Wang, Shou Zhen, et al.
Publicado: (2014)